Mentions
Extended reach
Total likes
Video views
AI synopsis
Participants often reference specific findings from the research, like the enhanced fusogenicity of the BA.5 subvariant compared to BA.1 and BA.2. Comments include phrases such as 'urgent investigation' and 'strong inflammatory response,' which convey a tone of concern and urgency. The use of scientific vocabulary and quick-follow-up discussions about implications emphasizes the significance of the publication in the context of ongoing COVID-19 management.
The majority of discussions indicate general support for the findings presented in the publication, with users often highlighting the differences between the Omicron subvariants.
There is a strong level of curiosity displayed, with many participants discussing the publication's implications and details, suggesting that the topic resonates significantly with users.
While the depth of engagement varies, several comments reference specific scientific findings and their implications, showing that users are not just skimming but are actively processing the information.
Many believe that the findings of the publication could substantially influence ongoing research and public health strategies, as indicated by the frequent mention of BA.5's heightened pathogenicity.
"Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kinetics of BA.5 was comparable among the Omicron subvariants, BA.5 was much more fusogenic than BA.1 and BA.2." https://t.co/p52BpAvDAw https://t.co/0WKmRel9bY
" Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/vC0WJDh1rg
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | Communications Biology https://t.co/C0u7j7o8e4
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 Airway-on-a-chip analysis showed that, among Omicron subvariants, BA.5 had enhanced ability to disrupt the respiratory epithelial and endothelial barriers. https://t.co/sGKK3NWr0n
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/WoCFP7jDf4 #biorxiv_micrbio
Preliminary report; Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5: Unremitting emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants imposes us to continuous control… Read more ↓ https://t.co/vhYlJW4g0R
This video presents an analysis of the comparative pathogenicity of SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.5. Using animated race charts, we contrast their relative progressions over a 72-hour period…
This video analyzes the comparative pathogenicity of SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.5. It highlights the enhanced fusogenicity and greater respiratory barrier disruption of BA.5, alongside its…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
Virological features of Omicron subvariants in vitro. From: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/jsHvLZADPY
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | Communications Biology https://t.co/C0u7j7o8e4
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
RT @ejustin46: "Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kine…
"Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5" "Although in vitro growth kinetics of BA.5 was comparable among the Omicron subvariants, BA.5 was much more fusogenic than BA.1 and BA.2." https://t.co/p52BpAvDAw https://t.co/0WKmRel9bY
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 Airway-on-a-chip analysis showed that, among Omicron subvariants, BA.5 had enhanced ability to disrupt the respiratory epithelial and endothelial barriers. https://t.co/sGKK3NWr0n
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/RhFTCx1iPJ
Time-course dynamics of Omicron subvariants in vivo. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/Bczp6eMweQ
Virological features of Omicron subvariants in vitro. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/JG5R33zl2j
RT @hichachu: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | bioRxiv 日本から BA.5を他のオミクロン亜系統BA.1…
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | bioRxiv 日本から BA.5を他のオミクロン亜系統BA.1、BA.2、および祖先のB.1.1と総合的に解析した。BA.5のin vitro成長速度はOmicron変異株の中で同等であるがBA.5はBA.1やBA.2 https://t.co/YDq88A7ALN
RT @MichiWagner4: " Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SA…
New: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/LTn2VzR7ao read/write/request review https://t.co/RnurTL3DyM #coronavirus #COVID19
RT @MichiWagner4: " Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SA…
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/HRE9gIuQCd New Omicron subvariant named BA.5 is urgently required for characterization. In vitro growth...
RT @MichiWagner4: " Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SA…
RT @MichiWagner4: " Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SA…
RT @MichiWagner4: " Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SA…
" Importantly, inflammatory response against BA.5 is strong compared with BA.1 and BA.2" Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/vC0WJDh1rg
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | bioRxiv https://t.co/29gYDi3VA3
Coronavirus: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 | bioRxiv https://t.co/M7s2Is81Sv
Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda et al., The Genotype to Phenotype Japan (G2P-Japan) Consortium, Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5, bioRxiv 2022.08.05.502758; doi: https://t.co/VvWGyHiTnX https://t.co/mlwhapxS9q
Preliminary report; Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5: Unremitting emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants imposes us to continuous control… Read more ↓ https://t.co/vhYlJW4g0R
RT @biorxiv_micrbio: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/WoCFP7jDf4 #b…
RT @biorxiv_micrbio: Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/WoCFP7jDf4 #b…
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/WoCFP7jDf4 #biorxiv_micrbio
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 https://t.co/QutNTmkHdg #bioRxiv